Remnant cholesterol and triglyceride-rich lipoproteins: what human genetics tells us about causality beyond LDL

30 August 2026 (17:30 - 17:42)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Anne Tybjaerg-Hansen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail

Lp(a), aortic valve stenosis, and atherosclerosis

Doctor S. Kraler (Zurich, CH)

Presentation thumbnail

Emerging mechanisms controlling immunoinflammatory response during atherogenesis

Miss M. Depuydt (Amsterdam, NL)

Presentation thumbnail

Targeting deoxyribonucleic acid and ribonucleic acid in the context of lipid-lowering and vascular disorders

Professor N. Bouatia-Naji (Paris, FR)

Presentation thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion

Access the full session

Session thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein?

The Event

Event poster

ESC Congress 2026

30 August 2026 17:30 CET

You may be interested in

Congress Presentation

State-of-the-art lecture on cardiovascular residual risk management: role of triglycerides and remnant cholesterol

26 August 2023

Congress Presentation

Genetic workup for dyslipidaemias: when and what to do? how to interpret?

24 April 2026

Congress Presentation

Elevated remnant cholesterol explains a substantial part of excess cardiovascular risk in the metabolic syndrome

29 August 2026

Congress Presentation

Differential associations of lipoprotein(a)-associated cholesterol and triglycerides with coronary plaque burden and vulnerability: a PROSPECT II substudy

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources